Sulfo-N-succinimidyl oleate (SSO), another CD36 antagonist, reduces proliferation in CRC cells and tumor growth in xenografts, upregulates the epithelial marker E-cadherin, and inhibits cell migration in HCC [282]. Here, CD36 is linked to colorectal carcinoma.